SCHEMBL8920154

SCHEMBL8920154

c1ccc(-n2ccnc2)c(Cc2ccc3cccnc3c2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCOA3 Q9Y6Q9 1/20 0.47
CYP19A1 P11511 4/20 0.42
CYP11B1 P15538 3/20 0.42
CYP11B2 P19099 3/20 0.42
IDO1 P14902 1/20 0.40
HTR5A P47898 1/20 0.40
RAB9A P51151 2/20 0.39
NPC1 O15118 1/20 0.39
CASP3 P42574 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
CYP3A4 P08684 3/20 0.39
ALDH1A1 P00352 3/20 0.38
MEN1 O00255 3/20 0.38
CYP1A2 P05177 3/20 0.38
CYP2C19 P33261 3/20 0.38
KMT2A Q03164 3/20 0.38
LMNA P02545 2/20 0.38
CYP2D6 P10635 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9196161 0.86 IDO1 (0.43) NCOA3CYP19A1CYP11B1CYP11B2IDO1
Sulfuric Acid SCHEMBL9485614 0.84 NCOA3 (0.50) NCOA3CYP19A1CYP11B1CYP11B2IDO1
SCHEMBL7455193 0.79 IDO1 (0.39) CYP19A1CYP11B1CYP11B2IDO1HTR5A
SCHEMBL7463718 0.79 NPC1 (0.44) CYP11B1CYP11B2IDO1HTR5ARAB9A
SCHEMBL9663760 0.77 CBFB (0.57) RAB9ANPC1KMT2ALMNAMAPT
SCHEMBL9077581 0.77 IDO1 (0.47) CYP19A1CYP11B1CYP11B2IDO1HTR5A
SCHEMBL9836179 0.77 IDO1 (0.53) CYP19A1CYP11B1CYP11B2IDO1HTR5A
SCHEMBL7453705 0.77 HTR5A (0.40) CYP19A1CYP11B1CYP11B2IDO1HTR5A
SCHEMBL9663508 0.77 IDO1 (0.37) CYP19A1CYP11B1CYP11B2IDO1HTR5A
SCHEMBL9195882 0.77 HTR5A (0.44) NCOA3CYP19A1CYP11B1CYP11B2IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5612354-A CONTROLLING CELL GROWTH AND DIFFERENTIATION, RETINOIC ACID METABOLISM JANSSEN PHARMACEUTICA N.V. (BE) 1997-03-18 US disclosed
EP-0371564-A2 (1H-azol-1-ylmethyl)substituted quinoline, quinazoline or quinoxaline derivatives JANSSEN PHARMACEUTICA N.V. (BE) 1990-06-06 EP disclosed